Search Results

PECARN
Specialty

PECARN

PECARN is the first federally-funded multi-institutional network for research in pediatric emergency medicine in the United States.

Article

Research

We are motivated to improve the outcomes of children requiring rehabilitation services through research and innovation. 

Article

YOU Matter Program

We support the emotional and mental wellbeing of employees dealing with work related, and potentially traumatic stressors, through the YOU Matter program. Learn more about our second victim resources for hospital staff.

Femoroacetabular Impingement

Femoroacetabular impingement (FAI) is a condition where extra bone grows on the bone(s) within the hip joint.

Constipation
Condition

Constipation

Many children have constipation at one time or another. Constipation can be defined as more than three days between bowel movements; stools that are large, hard and painful to pass; or incomplete bowel movements and stool backs up in the bowel despite daily bowel movements.

Nationwide Children’s Hospital Names Ray Bignall, MD, Chief Diversity and Health Equity Officer
News

Nationwide Children’s Hospital Names Ray Bignall, MD, Chief Diversity and Health Equity Officer

Nationwide Children’s Hospital announced today that O. N. Ray Bignall II, MD, FAAP, FASN, has been named the hospital’s chief diversity and health equity officer.

Article

Low Maintenance Contraceptives

Low maintenance contraceptives, also called Long Acting Reversible Contraception (LARC,) are the most effective reversible methods of birth control available to reduce unplanned teen pregnancy.

Sialorrhea (Drooling)
Condition

Sialorrhea (Drooling)

Sialorrhea, also known as hypersalivation or drooling, means excessive saliva flow. Anterior sialorrhea is when patients have forward spillage of saliva from their mouths onto their faces and clothes. Posterior sialorrhea is when patients have spillage of saliva from their mouths down their airways.

Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
News

Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England Journal of Medicine. The study was conducted by Researchers from Nationwide Children’s Hospital in collaboration with AveXis, Inc. and The Ohio State University College of Medicine.

Post-Surgery
Article

Post-Surgery

Learn what happens immediately after your child leaves the operating room and recovers in our Cardiothoracic Intensive Care Unit (CTICU).

Most Popular Pages
Specialty

Asthma Program

Specialty

Clinical Therapies

Condition

Headaches

Condition

Nasal Congestion